 |
| |
| Dec-20-17 | Initiated |
Ladenburg Thalmann |
Buy |
$34.25 |
|
| Sep-27-17 | Downgrade |
Citigroup |
Buy → Neutral |
|
|
| Aug-15-17 | Initiated |
Citigroup |
Buy |
$16 |
|
| Aug-14-17 | Initiated |
Wells Fargo |
Outperform |
$17 |
|
| Aug-14-17 | Initiated |
Jefferies |
Buy |
$16 |
|
|
|
| Aug-10-18 09:50AM | Gene-editing startups ignite the next 'Frankenfood' fight Reuters |
| 02:03AM | Insight: Gene-editing startups ignite the next 'Frankenfood' fight Reuters |
| Aug-02-18 07:55AM | Factors of Influence in 2018, Key Indicators and Opportunity within MTS, First Financial Bankshares, Tribune Media, Calyxt, McGrath RentCorp, and NorthWestern New Research Emphasizes Economic Growth GlobeNewswire |
| 07:30AM | Calyxt (CLXT) Reports Q2 Loss, Tops Revenue Estimates Zacks |
| 05:08AM | Calyxt: 2Q Earnings Snapshot Associated Press |
| Aug-01-18 06:13PM | Calyxt Reports Financial Results for Second Quarter and Half-Year 2018 Business Wire |
| Jul-30-18 07:30AM | Market Trends Toward New Normal in McDonald's, Calyxt, Ultra Petroleum, Crocs, The Progressive, and AmerisourceBergen Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire |
| Jul-20-18 03:06AM | Battle lines drawn as EU court weighs fate of gene-edited crops Reuters |
| Jul-19-18 08:00AM | Calyxt and S&W Seed Company Announce Milestone in Alfalfa Seed Development Program Business Wire |
| Jul-12-18 10:09AM | Zacks Industry Outlook Highlights: Archer Daniels Midland, Calyxt and Adecoagro Zacks |
| Jul-11-18 05:32AM | Calyxt Sees Hammer Chart Pattern: Time to Buy? Zacks |
| May-23-18 07:30AM | Report: Developing Opportunities within MFA Financial, Stewart Information Services, Eagle Bulk Shipping, Monmouth Real Estate Investment, Granite Point Mortgage Trust, and Calyxt Future Expectations, Projections Moving into 2018 GlobeNewswire |
| May-22-18 04:00PM | Calyxt Announces Successful Closing of $60.9 Million Public Offering Business Wire |
| May-21-18 08:30AM | Cellectis S.A.: Calyxt Announces Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire |
| May-15-18 05:50PM | Calyxt Announces Launch of Proposed Follow-On Offering Business Wire |
| 04:41PM | Bayer CropScience, LP Agrees to Settle Lawsuit Filed by Calyxt in Delaware Chancery Court Business Wire |
| May-07-18 06:21PM | Calyxt: 1Q Earnings Snapshot Associated Press |
| 04:30PM | Calyxt Reports Financial Results for First Quarter 2018 Business Wire |
| Apr-25-18 05:00PM | Calyxt to Hold First Quarter 2018 Investor Conference Call on Tuesday, May 8, at 8 a.m. EDT 7 a.m. CDT Business Wire |
| Apr-05-18 05:00PM | Calyxt Exceeds Farmer Adoption Milestone for High-Oleic Soybean Product Launch Business Wire |
| Mar-30-18 08:25AM | Consolidated Research: 2018 Summary Expectations for RadNet, Molecular Templates, Federated Investors, Kadant, Heartland Financial, and Calyxt Fundamental Analysis, Key Performance Indications GlobeNewswire |
| Mar-21-18 04:30PM | Calyxts High Fiber Wheat Deemed Non-Regulated by USDA Business Wire |
| Mar-13-18 06:45PM | Calyxt Reports Financial Results for Fourth Quarter and Full-Year 2017 Business Wire |
| Mar-12-18 08:34PM | Calyxt Filed Complaint in Delaware Chancery Court Against Bayer CropScience, LP Business Wire |
| Mar-05-18 04:30PM | Calyxt to Hold Fourth Quarter and Full-Year 2017 Investor Conference Call on Wednesday, March 14, at 8 a.m. EDT 7 a.m. CDT Business Wire |
| Mar-01-18 08:00AM | Calyxt Expands Total Acreage with Farmers for High-Oleic Soybean Product Business Wire |
| Jan-30-18 07:30AM | Consolidated Research: 2018 Summary Expectations for Immune Design, Primoris Services, Scotts Miracle-Gro, Heska, Calyxt, and Urstadt Biddle Properties Fundamental Analysis, Key Performance Indications GlobeNewswire |
| Dec-12-17 04:30PM | Calyxt and Farmers Business Network, Inc. Partner to Expand Grower Base for Calyxts Identity-Preserved High Oleic Soybeans Business Wire +5.23% |
| Nov-13-17 04:29PM | Calyxt Reports Financial Results for Third Quarter and First Nine Months of 2017 Business Wire |
| Nov-08-17 01:58PM | Calyxt, Inc. breached its 50 day moving average in a Bearish Manner : CLXT-US : November 8, 2017 Capital Cube |
| Oct-02-17 08:00AM | Calyxt and S&Ws Gene-Edited Alfalfa Plant Designated as Non-Regulated by USDA Business Wire +7.80% |
| Sep-25-17 04:45PM | Calyxt to Present at the Ladenburg Thalmann 2017 Healthcare Conference Business Wire |
| 04:30PM | Calyxt Advances Herbicide-Tolerant Wheat and Improved Oil Composition Canola Product Candidates to Phase 1 Business Wire |
| 07:00AM | Earnings Review and Free Research Report: Calyxt Reported First Quarterly Results Post its IPO ACCESSWIRE |
| Sep-06-17 06:42PM | Calyxt to Break Ground on New Concept-to-Fork Facility in Roseville, Minn. Business Wire +5.57% |
| Jul-25-17 04:01PM | Calyxt Announces Full Exercise of Over-Allotment Option and Closing of its Initial Public Offering Business Wire |
| Jul-23-17 10:36AM | IPOs This Week: Real Estate Unicorn Redfin Leads Weeks IPOs 24/7 Wall St. |
| Jul-20-17 02:12PM | Minnesota Gene-Editing Company Calyxt Enters the Market With a Bang 24/7 Wall St. |
| 12:00PM | Calyxt Inc. shares soar in gene-editing company's market debut MarketWatch |
|
|
|
|
| Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans. The Company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in New Brighton, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Voytas Daniel F | Chief Science Officer | Aug 08 | Option Exercise | 3.71 | 4,083 | 15,165 | 97,065 | Aug 10 02:22 PM | | Voytas Daniel F | Chief Science Officer | Aug 08 | Sale | 17.48 | 4,083 | 71,372 | 92,982 | Aug 10 02:22 PM | | Voytas Daniel F | Chief Science Officer | Jul 20 | Option Exercise | 3.59 | 4,666 | 16,751 | 97,648 | Jul 24 08:03 PM | | Voytas Daniel F | Chief Science Officer | Jul 20 | Sale | 17.94 | 4,666 | 83,708 | 92,982 | Jul 24 08:03 PM | | Voytas Daniel F | Chief Science Officer | Jul 09 | Option Exercise | 3.71 | 4,083 | 15,165 | 97,065 | Jul 11 04:08 PM | | Voytas Daniel F | Chief Science Officer | Jul 09 | Sale | 17.84 | 4,083 | 72,822 | 92,982 | Jul 11 04:08 PM | | Godard Alain | Director | Jun 21 | Sale | 20.84 | 5,880 | 122,540 | 33,320 | Jun 25 02:57 PM | | Arbadji Michel | Director of Business Developme | Jun 20 | Option Exercise | 3.59 | 6,500 | 23,321 | 31,490 | Jun 22 03:49 PM | | Voytas Daniel F | Chief Science Officer | Jun 20 | Option Exercise | 3.59 | 4,666 | 16,751 | 97,648 | Jun 22 03:53 PM | | Voytas Daniel F | Chief Science Officer | Jun 20 | Sale | 20.56 | 4,666 | 95,910 | 92,982 | Jun 22 03:53 PM | | Arbadji Michel | Director of Business Developme | Jun 20 | Sale | 22.00 | 6,500 | 143,000 | 24,990 | Jun 22 03:49 PM | | Sahoo Manoj | Chief Commercial Officer | Jun 18 | Sale | 20.51 | 490 | 10,050 | 81,634 | Jun 19 03:08 PM | | Cellectis S.A. | 10% Owner | Jun 15 | Buy | 19.49 | 63,175 | 1,231,281 | 22,713,175 | Jun 15 02:19 PM | | Corkal Bryan W.J. | Chief Financial Officer | Jun 15 | Sale | 18.77 | 5,093 | 95,613 | 73,307 | Jun 18 03:54 PM | | Arbadji Michel | Director of Business Developme | Jun 15 | Sale | 18.75 | 4,410 | 82,706 | 24,990 | Jun 18 03:43 PM | | Voytas Daniel F | Chief Science Officer | Jun 15 | Sale | 19.49 | 7,539 | 146,935 | 92,982 | Jun 15 06:31 PM | | Tripodi Federico A. | Chief Executive Officer | Jun 15 | Sale | 19.49 | 14,700 | 286,503 | 181,300 | Jun 15 06:28 PM | | Sahoo Manoj | Chief Commercial Officer | Jun 15 | Sale | 19.49 | 5,096 | 99,321 | 82,124 | Jun 15 06:22 PM | | Kozicz-Stankiewicz Anna Ewa | Director | Jun 15 | Sale | 19.49 | 1,000 | 19,490 | 18,600 | Jun 15 06:19 PM | | Dumont Philippe | Director | Jun 15 | Sale | 19.49 | 706 | 13,760 | 19,294 | Jun 15 06:15 PM | | Bowers Glenn R | Vice President of Breeding | Jun 15 | Sale | 19.49 | 423 | 8,244 | 8,617 | Jun 15 06:11 PM | | Choulika Andre | Director | Jun 15 | Sale | 19.49 | 2,352 | 45,840 | 154,448 | Jun 15 02:38 PM | | Voytas Daniel F | Chief Science Officer | May 21 | Option Exercise | 3.59 | 4,666 | 16,751 | 105,187 | May 23 03:16 PM | | Voytas Daniel F | Chief Science Officer | May 21 | Sale | 16.63 | 4,666 | 77,589 | 100,521 | May 23 03:16 PM | | Voytas Daniel F | Chief Science Officer | May 08 | Option Exercise | 3.71 | 4,083 | 15,165 | 104,604 | May 10 06:09 PM | | Voytas Daniel F | Chief Science Officer | May 08 | Sale | 15.58 | 4,083 | 63,596 | 100,521 | May 10 06:09 PM | | Voytas Daniel F | Chief Science Officer | Apr 20 | Option Exercise | 3.59 | 4,666 | 16,751 | 105,187 | Apr 24 06:13 PM | | Voytas Daniel F | Chief Science Officer | Apr 20 | Sale | 16.87 | 4,666 | 78,701 | 100,521 | Apr 24 06:13 PM | | Voytas Daniel F | Chief Science Officer | Apr 09 | Option Exercise | 3.71 | 4,083 | 15,165 | 104,604 | Apr 11 07:47 PM | | Voytas Daniel F | Chief Science Officer | Apr 09 | Sale | 14.38 | 4,083 | 58,734 | 100,521 | Apr 11 07:47 PM | | Voytas Daniel F | Chief Science Officer | Mar 20 | Option Exercise | 3.59 | 4,666 | 16,741 | 4,666 | Mar 22 07:25 PM | | Voytas Daniel F | Chief Science Officer | Mar 20 | Sale | 17.91 | 4,666 | 83,561 | 0 | Mar 22 07:25 PM | | Godard Alain | Director | Mar 12 | Option Exercise | 3.59 | 10,000 | 35,878 | 49,200 | Mar 13 06:22 PM | | Godard Alain | Director | Mar 12 | Sale | 19.00 | 10,000 | 190,000 | 39,200 | Mar 13 06:22 PM | | Godard Alain | Director | Mar 09 | Option Exercise | 3.59 | 10,000 | 35,875 | 49,200 | Mar 13 06:22 PM | | Godard Alain | Director | Mar 09 | Sale | 19.00 | 10,000 | 190,000 | 39,200 | Mar 13 06:22 PM | | Godard Alain | Director | Mar 05 | Option Exercise | 3.59 | 10,000 | 35,875 | 49,200 | Mar 13 06:22 PM | | Godard Alain | Director | Mar 05 | Sale | 19.00 | 10,000 | 190,000 | 39,200 | Mar 13 06:22 PM | | Arbadji Michel | Director of Business Developme | Feb 28 | Option Exercise | 3.59 | 3,500 | 12,557 | 32,900 | Mar 02 02:02 PM | | Arbadji Michel | Director of Business Developme | Feb 28 | Sale | 18.63 | 3,500 | 65,220 | 29,400 | Mar 02 02:02 PM | | Godard Alain | Director | Feb 22 | Sale | 19.00 | 400 | 7,600 | 39,200 | Feb 22 06:09 PM | | Godard Alain | Director | Feb 21 | Option Exercise | 3.58 | 13,700 | 49,046 | 52,900 | Feb 22 06:09 PM | | Godard Alain | Director | Feb 21 | Sale | 19.19 | 13,300 | 255,200 | 39,600 | Feb 22 06:09 PM | | Sahoo Manoj | Chief Commercial Officer | Feb 21 | Sale | 19.19 | 5,880 | 112,851 | 87,220 | Feb 22 05:53 PM | | Godard Alain | Director | Feb 20 | Option Exercise | 3.71 | 6,125 | 22,724 | 45,325 | Feb 22 06:09 PM | | Godard Alain | Director | Feb 20 | Sale | 20.70 | 6,125 | 126,804 | 39,200 | Feb 22 06:09 PM | | Sahoo Manoj | Chief Commercial Officer | Feb 20 | Sale | 20.69 | 4,900 | 101,362 | 93,100 | Feb 22 05:53 PM | | Corkal Bryan W.J. | Chief Financial Officer | Feb 20 | Sale | 20.73 | 19,600 | 406,229 | 78,400 | Feb 22 05:39 PM |
|
|
|
|
|
|
